Data / Drug companies / Steriscience Specialties Private Limited
Steriscience Specialties Private Limited: 13 products in the FDA NDC directory, labeler code 82449
Updated November 6, 2026. Source: US Food and Drug Administration, National Drug Code Directory (openFDA).
Steriscience Specialties Private Limited (labeler code 82449) lists 13 products in the FDA National Drug Code Directory, covering 9 finished drugs by generic name. By type: 13 prescription drugs. Its main marketing category is generic drugs (ANDA). The newest product started marketing on July 28, 2026.
The request: Watch Steriscience Specialties Private Limited (FDA labeler code 82449): each new product listing and each discontinued product. $10 of work on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.
- Labeler code
- 82449
- Products in commercial distribution
- 13
- Packages
- 14
- Finished drugs by generic name
- 9
- Prescription products
- 13
- Over the counter products
- 0
- Flagged as original packager
- 12 of 12 products that carry the flag
- Started marketing in the last 12 months
- 8
- Earliest marketing start
- March 8, 2024
- openFDA record search
- api.fda.gov
Products by marketing category
Share of the company's products in commercial distribution.
| Marketing category | Products | Share |
|---|---|---|
| Generic drugs (ANDA) | 12 | 92.3% |
| New drug applications (NDA) | 1 | 7.7% |
Products by type
| Type | Products | Share |
|---|---|---|
| Prescription drugs | 13 | 100% |
Drugs it lists
Finished drugs by generic name, with how many companies list each.
| Drug | Products | Companies listing it |
|---|---|---|
| Vancomycin hydrochloride | 3 | 39 |
| Methylene blue | 2 | 15 |
| Sugammadex sodium | 2 | 5 |
| Succinylcholine chloride | 1 | 27 |
| Ziprasidone mesylate | 1 | 9 |
| Doxycycline | 1 | 63 |
| Sodium bicarbonate | 1 | 51 |
| Rocuronium bromide | 1 | 25 |
| Fosaprepitant dimeglumine | 1 | 12 |
Dosage forms
| Dosage form | Products | Share |
|---|---|---|
| Injection, solution | 5 | 38.5% |
| Injection, powder, lyophilized, for solution | 5 | 38.5% |
| Solution | 2 | 15.4% |
| Injection | 1 | 7.7% |
Pharmacologic classes
FDA established pharmacologic classes of its products.
Newest products
By marketing start date.
| Product | Product NDC | Dosage form | Marketing category | Marketing start |
|---|---|---|---|---|
| Sugammadex sodium | 82449-242 | Solution | Generic drugs (ANDA) | July 28, 2026 |
| Sugammadex sodium | 82449-241 | Solution | Generic drugs (ANDA) | July 28, 2026 |
| Doxycycline | 82449-008 | Injection, powder, lyophilized, for solution | Generic drugs (ANDA) | May 10, 2026 |
| Methylene blue | 82449-003 | Injection, solution | Generic drugs (ANDA) | January 7, 2026 |
| Ziprasidone Mesylate | 82449-004 | Injection, powder, lyophilized, for solution | Generic drugs (ANDA) | December 19, 2025 |
| Vancomycin Hydrochloride | 82449-007 | Injection, powder, lyophilized, for solution | Generic drugs (ANDA) | December 15, 2025 |
| Vancomycin Hydrochloride | 82449-006 | Injection, powder, lyophilized, for solution | Generic drugs (ANDA) | December 15, 2025 |
| Vancomycin Hydrochloride | 82449-005 | Injection, powder, lyophilized, for solution | Generic drugs (ANDA) | December 15, 2025 |
| Methylene blue | 82449-002 | Injection, solution | Generic drugs (ANDA) | February 28, 2025 |
| Rocuronium Bromide | 82449-001 | Injection, solution | Generic drugs (ANDA) | November 30, 2024 |
| Succinylcholine Chloride | 82449-232 | Injection, solution | Generic drugs (ANDA) | September 30, 2024 |
| Focinvez | 82449-231 | Injection | New drug applications (NDA) | June 26, 2024 |
| Sodium Bicarbonate | 82449-000 | Injection, solution | Generic drugs (ANDA) | March 8, 2024 |
CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.